Chemistry of Therapeutic Oligonucleotides That Drives Interactions with Biomolecules
Oligonucleotide therapeutics that can modulate gene expression have been gradually developed for clinical applications over several decades. However, rapid advances have been made in recent years. Artificial nucleic acid technology has overcome many challenges, such as (1) poor target affinity and s...
Main Authors: | Chisato Terada, Seiya Kawamoto, Asako Yamayoshi, Tsuyoshi Yamamoto |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-11-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/14/12/2647 |
Similar Items
-
Therapeutic Oligonucleotides: An Outlook on Chemical Strategies to Improve Endosomal Trafficking
by: Priyanka Mangla, et al.
Published: (2023-09-01) -
Lipid and Peptide-Oligonucleotide Conjugates for Therapeutic Purposes: From Simple Hybrids to Complex Multifunctional Assemblies
by: Carme Fàbrega, et al.
Published: (2023-01-01) -
The role of chemistry in the success of oligonucleotides as therapeutics
by: Pawan Kumar, et al.
Published: (2022-02-01) -
Delivery of Oligonucleotides Using a Self-Degradable Lipid-Like Material
by: Hiroki Tanaka, et al.
Published: (2021-04-01) -
The Medicinal Chemistry of Artificial Nucleic Acids and Therapeutic Oligonucleotides
by: Miklós Bege, et al.
Published: (2022-07-01)